-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Assumes Innoviva at Outperform, Announces Price Target of $35

Benzinga·09/23/2026 12:15:04
Oppenheimer analyst Les Sulewski assumes Innoviva (NASDAQ:INVA) with a Outperform rating and announces Price Target of $35.